Search for: ""Daubert v. Merrell Dow Pharmaceuticals, Inc." OR "509 U.S. 579""
Results 81 - 100
of 112
Sorted by Relevance
|
Sort by Date
30 Oct 2013, 10:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 599 (1993) (Rehnquist, C.J., concurring in part and dissenting in part) (“the various briefs filed in this case … deal with definitions of scientific knowledge, scientific method, scientific validity, and peer review—in short, matters far afield from the expertise of judges”); Marconi Wireless Telegraph Co. [read post]
16 Jan 2013, 5:19 am
Merrell Dow Pharmaceuticals, Inc. [read post]
21 Oct 2017, 9:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]
11 Feb 2013, 4:37 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
13 Sep 2019, 6:00 am
[vi]And then-Justice Rehnquist might have joined the majority in Washington v. [read post]
27 Feb 2014, 5:49 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993), and need not find facts when evidence is disputed in these cases. [ ] In 2005, the Federal Circuit sat en banc in Phillips. [read post]
12 Nov 2014, 8:01 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 599 (1993) (Rehnquist, C.J., concurring in part and dissenting in part) (‘‘the various briefs filed in this case … deal with definitions of scientific knowledge, scientific method, scientific validity, and peer review—in short, matters far afield from the expertise of judges’’); Marconi Wireless Telegraph Co. of America v. [read post]
4 Aug 2010, 7:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) established the test federal (and many state) judges currently use to determine the admissibility of expert testimony in trials and other proceedings. [read post]
13 Jun 2017, 4:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), where the Supreme Court ruled that, under the federal evidence rules, “the trial judge must ensure that any and all scientific testimony or evidence admitted is not only relevant, but reliable” in light of several factors enumerated by the Court. [read post]
19 Sep 2008, 8:13 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
27 Feb 2024, 12:07 pm
This would be a Scott v. [read post]
6 Apr 2016, 12:06 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]
18 Sep 2019, 10:02 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S. [read post]
11 May 2020, 1:09 am
That was the tradition that stood in active need of reform when Daubert was decided in 1993. [read post]
6 Feb 2014, 6:31 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993), and need not find facts when evidence is disputed in these cases.[10] In 2005, the Federal Circuit sat en banc in Phillips. [read post]
28 May 2015, 2:29 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993). [read post]
15 Dec 2009, 1:56 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993)]). [read post]
17 Jun 2021, 12:29 pm
As a result, so-called Daubert hearings began taking place in district courts around the country, in parallel with other centralized proceedings in MDL 926. [read post]
10 Mar 2008, 1:10 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993); General Electric Co. v. [read post]
17 Nov 2018, 12:10 pm
To be sure, judges have often poorly expressed their reasoning for deciding scientific evidentiary issues, and perhaps poor communication or laziness by judges was responsible for Rothman’s interest in joining the Daubert fray. [read post]
